Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-15

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved the original application for the generic fixed-dose combination of irbesartan and hydrochlorothiazide from Alembic Pharmaceuticals Limited for hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)